Market Tracker

08/01 6:05pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

8.56
Data as of Aug 01
 -0.10 / -1.15%
Today’s Change
5.84
Today|||52-Week Range
11.47
+13.53%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close8.66
Today’s open8.64
Day’s range8.38 - 8.82
Volume211,894
Average volume (3 months)449,627
Market cap$364.1M
Dividend yield--
Data as of 3:59pm ET, 08/01/2014

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+67.03%
Earnings growth (next 5 years)--
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book10.35

Competitors

 Today’s
change
Today’s
% change
SNTASynta Pharmaceutical...-0.10-2.53%
NWBONorthwest Biotherape...-0.05-0.76%
DRTXDurata Therapeutics ...-0.06-0.47%
SGYPSynergy Pharmaceutic...-0.04-1.10%
Data as of 3:59pm ET, 08/01/2014

Financials

Next reporting dateAugust 8, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts